– CANADA, Vancouver – RavenQuest BioMed Inc. (CSE: RQB | OTC: RVVQF | FRA:1IT), today announced that Usama Chaudhry and Jatinder Dhaliwal have been appointed directors of the Company. Mr. Chaudhry has also been appointed as interim CFO for the Company.
RavenQuest further announces the resignations from the board of Anton Drescher, Hendrik van Alphen and David Cross, CFO.
“As our Company continues to evolve, we see it as utmost importance to ensure our board is comprised of those that can most help our Company grow the business and achieve our potential,” said George Robinson, RavenQuest CEO.
“I am confident that RavenQuest’s long term growth priorities will be well-served by these changes, providing new leadership as we work toward profitability in 2020. David Cross will provide advisory accounting services to ensure a smooth transitional period while we complete our year-end financials.” Robinson continued.
“RavenQuest wishes to thank Messrs. Drescher, van Alphen and Cross for their contribution to RavenQuest. As we grew our technology from a concept into a scaled-up reality, they provided key guidance through our nascent development years,” stated Robinson, RavenQuest CEO.
About Usama Chaudhry
Mr. Chaudhry is an experienced businessman who will join the board as an independent director. Mr. Chaudhry sits on a number of public company boards and specializes in executive management services, including corporate development, investor relations, financial reporting, company filings, budgeting and overseeing corporate governance, while achieving company objectives and maintaining internal cost controls.
About Jatinder Dhaliwal
Jatinder “Jay” Dhaliwal is a registered pharmacist and intern CEO of Global Health Clinics. He extensive knowledge of agricultural, medical and pharmaceutical operations. Jay holds a bachelor of pharmacy from the University of British Columbia and a bachelor of science in biology from the University of Victoria. Jay is a certified medical cannabis practitioner. “I have seen first hand the benefits medical cannabis provides patients. I believe every patient that qualifies should be given the opportunity to use this life-changing treatment and we need to work to change the stigma around it.”
About RavenQuest BioMed Inc.
RavenQuest is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development. RavenQuest is a licensed producer with facilities located in Markham, Ontario and Edmonton, Alberta.
RavenQuest maintains a research partnership with McGill University focused upon cultivar recognition, plant stabilization and yield maximization of the cannabis plant. The Company also focuses on partnerships with Indigenous communities.
For more information: https://rqbglobal.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
Comments are closed.